Remission rates increase substantially by adding adalimumab to methotrexate and intra-articular glucocorticoid in patients with early rheumatoid arthritis – 1-year results of investigator-initiated, double-blinded randomized clinical trial (OPERA).
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Original language | English |
---|---|
Book series | Scandinavian Journal of Rheumatology. Supplement |
Volume | 41 |
Issue number | 126 suppl. |
Pages (from-to) | 17-8 |
Number of pages | 2 |
ISSN | 1502-7740 |
Publication status | Published - 2012 |
ID: 48462979